Targeted modulation of the neuroinflammatory response after spinal cord injury: the ongoing quest for the "holy grail".
This Commentary discusses the role of inflammation after spinal cord injury.
Stahel
Philip F
PF
Department of Orthopaedic Surgery, University of Colorado Denver, School of Medicine Denver Health Medical Center, 777 Bannock Street, Denver, CO 80204, USA. philip.stahel@dhha.org
Flierl
Michael A
MA
D000818:Animals; D011415:Complement Factor B / Q000037:antagonists & inhibitors / Q000235:genetics / Q000276:immunology; D003170:Complement Pathway, Alternative / Q000276:immunology / Q000502:physiology; D006801:Humans; D007167:Immunotherapy / Q000379:methods / Q000639:trends; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008954:Models, Biological; D058990:Molecular Targeted Therapy / Q000379:methods / Q000639:trends*; D009187:Myelitis / Q000209:etiology / Q000276:immunology* / Q000473:pathology / Q000628:therapy*; D013119:Spinal Cord Injuries / Q000150:complications / Q000276:immunology* / Q000628:therapy*
D011415:Complement Factor B